A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Part of paid clinical trials in Aliso Viejo, California.
- Sponsor
- Oculis
- Study ID
- NCT07548632
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
- Dry Eye Disease (DED)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Artificial Tear Run-in — OTHERArtificial tear eye drop run-in three times daily (TID) for approximately 14 days.
- licaminlimab — DRUGLicaminlimab eye drops three times daily (TID) for 29 days.
- Vehicle of licaminlimab — OTHERInert ophthalmic solution vehicle of licaminlimab, three times daily (TID) for 29 days.
Study Details
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Key Dates
- Start date
- Apr 16, 2026
- Status verified
- May 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: licaminlimab60 mg/mL licaminlimab ophthalmic solution
- Placebo Comparator: VehicleVehicle of licaminlimab ophthalmic solution
Primary Outcome Measure
Change from baseline in global ocular discomfort severity score at Day 29 in participants with DED and specific TNFR1 genotype [ Time Frame: From Day 1 to Day 29 ]
Central Contacts
- Oculis Chief Development Officer617 928 5886
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| East West Eye Institute | Aliso Viejo | California | 92656 | - |
| Orange County Ophthalmology | Garden Grove | California | 92843 | - |
| Global Research Management | Glendale | California | 91204 | - |
| LoBue Laser and Eye Medical Center | Murrieta | California | 92562 | - |
| Eye Research Foundation | Newport Beach | California | 92664 | - |
| North Bay Eye Associates, Inc. | Petaluma | California | 94954 | - |
| Vision Institute | Colorado Springs | Colorado | 80907 | - |
| Segal Drug Trials, Inc. | Delray Beach | Florida | 33484 | - |
| Oculus Research, Inc. | Garner | North Carolina | 27529 | - |
| CORE, Inc | Shelby | North Carolina | 28150 | - |
| Scott & Christie and Associates | Cranberry Township | Pennsylvania | 16066 | - |
| Erie Retina Research | Erie | Pennsylvania | 16507 | - |
| Total Eye Care, PA | Memphis | Tennessee | 38119 | - |
| Piedmont Eye Center, Inc. | Lynchburg | Virginia | 24502 | - |
Find similar trials in Aliso Viejo, CA
Related Studies
- The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier FunctionPHASE4 · Recruiting · Southern California College of Optometry at Marshall B. Ketchum University · Fullerton, California
- SYSTANE® PRO vs. MIEBO™ in Dry Eye DiseasePHASE4 · Recruiting · Indiana University · Newport Beach, California
- Moderate-to-Severe Dry Eye Disease Relief Using AcoltremonEnrolling By Invitation · Colvard Kandavel Eye Center · Encino, California
- Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract SurgeryRecruiting · Vance Thompson Vision · Sioux Falls, South Dakota